Alan White explores alternative ways for life sciences firms to keep hold of experienced, qualified professionals as demand for pharmacovigilance skills soars.
Alan White
Advertisement
Alan White is CEO of Arriello, a specialist global provider of innovative, high-impact market access, regulatory affairs & pharmacovigilance solutions and services for pharma and biotech firms primarily in Europe and North America.
Articles by Alan White
Regulatory Process Innovation & The Dangers of Over-Promising with AI
Published: | Updated:
AI has huge potential, but the key to ROI is in the application, writes Alan White.
Advertisement
Latest Updated Articles
Regulatory Process Innovation & The Dangers of Over-Promising with AIPublished: October 10th 2019 | Updated: November 15th 2020
Money Isn't Everything: Beating Salary InflationPublished: February 4th 2020 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Real-World Data Brings New Insights to Natural History of Disease Studies
2
FDA Approves Hernexeos Under National Priority Voucher Program
3
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
4
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
5